We performed ex vivo immunoblotting and qRT-PCR analysis and detected decreases in levels of HER3, pHER3, pAKT, and pERK1/2 in LINC00052-shRNA tumor lysates in comparison with controls (Figure 5C and 5D). The gene discussed is ERBB3; the disease is neoplasm.